UniProt ID | PRDX5_HUMAN | |
---|---|---|
UniProt AC | P30044 | |
Protein Name | Peroxiredoxin-5, mitochondrial | |
Gene Name | PRDX5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 214 | |
Subcellular Localization |
Isoform Mitochondrial: Mitochondrion . Isoform Cytoplasmic+peroxisomal: Cytoplasm . Peroxisome matrix . Imported into peroxisomes via peroxisomal targeting signal 1 receptor PEX5. |
|
Protein Description | Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events.. | |
Protein Sequence | MGLAGVCALRRSAGYILVGGAGGQSAAAAARRYSEGEWASGGVRSFSRAAAAMAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | GVCALRRSAGYILVG HHHHHHHCCCEEEEE | 21.44 | 28555341 | |
31 (in isoform 2) | Ubiquitination | - | 33.09 | 21890473 | |
31 | Ubiquitination | QSAAAAARRYSEGEW HHHHHHHHHHCCCCC | 33.09 | 33845483 | |
34 | Phosphorylation | AAAARRYSEGEWASG HHHHHHHCCCCCCCC | 37.00 | 27251275 | |
34 | Ubiquitination | AAAARRYSEGEWASG HHHHHHHCCCCCCCC | 37.00 | 33845483 | |
45 | Phosphorylation | WASGGVRSFSRAAAA CCCCCHHHHHHHHHH | 25.76 | 32142685 | |
47 | Phosphorylation | SGGVRSFSRAAAAMA CCCHHHHHHHHHHCC | 23.43 | 17081983 | |
50 (in isoform 2) | Ubiquitination | - | 8.47 | 21890473 | |
50 | Ubiquitination | VRSFSRAAAAMAPIK HHHHHHHHHHCCCEE | 8.47 | 33845483 | |
57 | Ubiquitination | AAAMAPIKVGDAIPA HHHCCCEECCCEECE | 38.82 | 23503661 | |
64 | Ubiquitination | KVGDAIPAVEVFEGE ECCCEECEEEEECCC | 12.18 | 33845483 | |
75 | Acetylation | FEGEPGNKVNLAELF ECCCCCCEEEHHHHH | 38.11 | - | |
75 | Ubiquitination | FEGEPGNKVNLAELF ECCCCCCEEEHHHHH | 38.11 | 23503661 | |
83 | Acetylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 19608861 | |
83 (in isoform 1) | Ubiquitination | - | 80.56 | 21890473 | |
83 | Succinylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | - | |
83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 23000965 | |
83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 21890473 | |
83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 21890473 | |
83 | Succinylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 23954790 | |
85 | Ubiquitination | LAELFKGKKGVLFGV HHHHHCCCCEEEEEC | 47.12 | 23000965 | |
86 | Ubiquitination | AELFKGKKGVLFGVP HHHHCCCCEEEEECC | 64.02 | 23000965 | |
97 | Ubiquitination | FGVPGAFTPGCSKTH EECCCCCCCCCCCCC | 20.45 | 24816145 | |
97 | Phosphorylation | FGVPGAFTPGCSKTH EECCCCCCCCCCCCC | 20.45 | 25159151 | |
100 | S-nitrosocysteine | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | - | |
100 | Glutathionylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 22555962 | |
100 | S-nitrosylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 22178444 | |
100 | S-palmitoylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 29575903 | |
101 | Phosphorylation | GAFTPGCSKTHLPGF CCCCCCCCCCCCCCH | 46.64 | 28450419 | |
102 | Ubiquitination | AFTPGCSKTHLPGFV CCCCCCCCCCCCCHH | 44.00 | 21890473 | |
102 | Acetylation | AFTPGCSKTHLPGFV CCCCCCCCCCCCCHH | 44.00 | 25953088 | |
102 (in isoform 1) | Ubiquitination | - | 44.00 | 21890473 | |
116 | Ubiquitination | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 33845483 | |
116 | Succinylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | - | |
116 | Malonylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 26320211 | |
116 | Acetylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 25038526 | |
116 | Succinylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | - | |
118 | Ubiquitination | QAEALKAKGVQVVAC HHHHHHCCCCEEEEE | 59.01 | - | |
142 | Ubiquitination | GEWGRAHKAEGKVRL CCCCCCCCCCCCEEE | 47.34 | 24816145 | |
146 | Ubiquitination | RAHKAEGKVRLLADP CCCCCCCCEEEEECC | 18.71 | 29967540 | |
159 | Ubiquitination | DPTGAFGKETDLLLD CCCCCCCCHHCEECC | 51.49 | 29967540 | |
159 | Acetylation | DPTGAFGKETDLLLD CCCCCCCCHHCEECC | 51.49 | 25038526 | |
161 | Phosphorylation | TGAFGKETDLLLDDS CCCCCCHHCEECCCH | 35.12 | 20873877 | |
168 | Phosphorylation | TDLLLDDSLVSIFGN HCEECCCHHHHHHCC | 30.27 | 28258704 | |
171 | Phosphorylation | LLDDSLVSIFGNRRL ECCCHHHHHHCCCCH | 19.93 | 25693802 | |
182 | Phosphorylation | NRRLKRFSMVVQDGI CCCHHHEEEEEECCC | 18.07 | 28450419 | |
183 | Sulfoxidation | RRLKRFSMVVQDGIV CCHHHEEEEEECCCE | 2.92 | 21406390 | |
204 | Glutathionylation | PDGTGLTCSLAPNII CCCCCEEEECCHHHH | 3.64 | 22555962 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRDX5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRDX5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRDX5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CC90B_HUMAN | CCDC90B | physical | 16169070 | |
A4_HUMAN | APP | physical | 21832049 | |
STAM1_HUMAN | STAM | physical | 22939629 | |
SODC_HUMAN | SOD1 | physical | 22939629 | |
VAMP2_HUMAN | VAMP2 | physical | 22939629 | |
PRDX6_HUMAN | PRDX6 | physical | 22939629 | |
SUMO1_HUMAN | SUMO1 | physical | 22939629 | |
SC24A_HUMAN | SEC24A | physical | 22939629 | |
PTN23_HUMAN | PTPN23 | physical | 22939629 | |
SLD5_HUMAN | GINS4 | physical | 22939629 | |
RS12_HUMAN | RPS12 | physical | 22939629 | |
RD23B_HUMAN | RAD23B | physical | 22939629 | |
TOM40_HUMAN | TOMM40 | physical | 22939629 | |
UBE2B_HUMAN | UBE2B | physical | 22939629 | |
UBAP2_HUMAN | UBAP2 | physical | 22939629 | |
PTMS_HUMAN | PTMS | physical | 22939629 | |
IFT27_HUMAN | IFT27 | physical | 22939629 | |
PTGR1_HUMAN | PTGR1 | physical | 22939629 | |
UBE2A_HUMAN | UBE2A | physical | 22939629 | |
SSA27_HUMAN | SSSCA1 | physical | 22939629 | |
ANCHR_HUMAN | ZFYVE19 | physical | 22939629 | |
PSRC1_HUMAN | PSRC1 | physical | 22939629 | |
DUT_HUMAN | DUT | physical | 26344197 | |
NDKA_HUMAN | NME1 | physical | 26344197 | |
PARK7_HUMAN | PARK7 | physical | 26344197 | |
PRDX1_HUMAN | PRDX1 | physical | 26344197 | |
PRDX2_HUMAN | PRDX2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83, AND MASS SPECTROMETRY. |